Athos Therapeutics, Inc.
Pharmaceuticals · TORRANCE, CA
PharmaceuticalsSEC Form D
Athos Therapeutics, Inc. filed a Form D with the U.S. Securities and Exchange Commission on May 15, 2026, reporting $10,282,887 raised toward a $20,000,000 offering.
Incorporated in Delaware and based in TORRANCE, CA, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Athos Therapeutics, Inc. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- Dimitrios IliopoulosExecutive Officer · Director
- Allan J. PantuckExecutive Officer · Director
- Carl McKinzieDirector
- Joel CohenDirector
- Anthony ZingaleDirector
- Laurence SteinDirector
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$3.0MRaised
FibroBiologics, Inc.
$200.0KRaised
Balsam Pharmaceuticals Co
$750.0KRaised
Eos SENOLYTIX, Inc.
$1.9MRaised
Liminatus Pharma, Inc.
$384.8KRaised